期刊文献+

肺表面活性物质治疗早产儿肺透明膜病15例临床观察 被引量:1

下载PDF
导出
摘要 目的探讨外源性肺表面活性物质(PS)固尔苏治疗早产儿肺透明膜病(HMD)的方法及效果。方法采用气管插管、从气管内滴入PS,观察用药前后患儿症状、体征、动脉血氧分压(PaO2)、血氧饱和度(SaO2)、动脉血二氧化碳分压(PaCO2)及胸片。结果用药后,HMD患儿症状、体征渐减轻直至消失,PaO2、SaO2升高,PaCO2降低,14例于用药24h后PaO2、PaCO2、SaO2达到正常,胸片示肺野较用药前清晰,1例患儿死于肺炎。结论PS能改善HMD患肺顺应性及氧合功能;一次用药无效的患儿,部分经及时二次给药有效。
出处 《四川医学》 CAS 2007年第7期794-795,共2页 Sichuan Medical Journal
  • 相关文献

参考文献8

二级参考文献31

  • 1邓渊,董声焕,张广安,马金贵.可控闭泡式表面张力测定仪的研制[J].中国医疗器械杂志,1994,18(2):87-89. 被引量:6
  • 2周志荣,李振林.盐酸溴环己胺醇的临床应用[J].国外医学(呼吸系统分册),1995,15(2):97-98. 被引量:11
  • 3封志纯,梁巧明,张帆.肺表面活性物质雾化吸入治疗RDS[J].国外医学(儿科学分册),1996,23(1):20-23. 被引量:11
  • 4Dekowski SA, Hohzman RB. Surfactant replacement therapy: an update on applications[J ]. Pediatr Clin North Am, 1998 ; 45 ( 3 ) : 549 -572.
  • 5Lotze A, Mitchell BR, Bulas DI, et al. Multicenter study of surfactant(beractant)use in the treatment of term infants with revere respiratory failure: survanta in term infants study group [J ]. J Pediatr, 1998;132( 1 ) :40-47.
  • 6McColley SA. Bronchopulmonary dysplasia: impact of surfactant replacement therapy[ J ]. Pediatr Clin North Am, 1998 ;45 ( 3 ) : 573 -586.
  • 7Schulz S, Wiebalck A, Frankenberg C. Low dose surfactant instillation during extracorporeal membrane oxygenation therapy in a patient with adult respiratory distress syndrome and secondary atelectasis after chest contusion[ J ]. J Cardiothorac Vasc Anesth, 2000 ; 14 ( 1 ) :59 - 62.
  • 8Enhorning G, Hohlfeld J, Krug N, et al. Surfactant function affected by airway inflammation and cooling: possible impact on exercise-induced asthma[J]. Eur Respir J,2000; 15(3) :532-538.
  • 9Findtay RD, Taeusch HW, Walther FJ. Surfactant replacement therapy for meconium aspiration syndrome[ J ]. Pediatrics, 1996;97( 1 ) :48-52.
  • 10Hohlfeld J, Fabel H, Hamm H. The role of pulmonary surfactant in obstructive airway disease[ J ]. Europ Resp J, 1997 ; 10 : 482 - 491.

共引文献27

同被引文献11

  • 1Melchor SM,Octavio CM,Nazarea HM. Treatment of hyaline membrane disease in the preterm newborn with exogenous lung surfactant:a controlled study[J].{H}Gaceta Medica De Mexico,2005,(4):1047-1073.
  • 2Deng R,Tang BZ,Liu H. Risk factors on the occurrence and prognosis of neonatal hyaline membrane disease[J].Journal of Sichuan University[J].Medical science edition,2010,(4):688-691.
  • 3Martijn M,Frans HJ,Inez F. Changes in lung volume and ventilation during surfactant treatment in ventilated preterm infants[J].Am J Res Criti Cre Med,2011,(1):100-105.
  • 4Yan SX,Thomas L,Suzanne S. In-depth analysis of hyaline fibromatosis syndrome frameshift mutations at the same site reveal the necessity of personalized therapy[J].{H}Human Mutation,2013,(7):1005-1017.
  • 5Cherif A,Jemaa WB,Kacem S. Preeclampsia increases the risk of hyaline membrane disease in premature infant:A retrospective controlled study[J].Journal de gynecologie obstetrique et biologie de la reproduction,2008,(6):597-601.
  • 6Alan HJ. Recent increase in mortality from hyaline membrane disease[J].J pedia,2010,(4):558.
  • 7Sing SN,Malik GK,Prashanth GP. High frequency oscillatory ventilation versus synchronized intermittent mandatory ventilation in preterm neonates with Hyaline membrane disease:A randomized controlled trial[J].Indian pediat,2012,(5):405-408.
  • 8曾海权.肺表面活性物质与机械通气联合治疗新生儿肺透明膜病疗效观察[J].临床医学工程,2009,16(1):50-50. 被引量:3
  • 9叶毅桦,陈志凤,李锐钦,张素芬,黄莹.肺表面活性物质联合机械通气治疗早产儿肺透明膜病的疗效分析[J].广东医学,2009,30(2):290-291. 被引量:13
  • 10温伟珍,陈宏香,李炎.肺表面活性物质联合经鼻持续正压通气治疗新生儿肺透明膜病的临床研究[J].广西医学,2011,33(6):723-725. 被引量:6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部